HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
BörsenkürzelBEAT
Name des UnternehmensHeartbeam Inc
IPO-datumOct 14, 2021
CEOEno (Robert P)
Anzahl der mitarbeiter21
WertpapierartOrdinary Share
GeschäftsjahresendeOct 14
Addresse2118 Walsh Ave., Suite 210
StadtSANTA CLARA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl95050
Telefon14088994443
Websitehttps://www.heartbeam.com/
BörsenkürzelBEAT
IPO-datumOct 14, 2021
CEOEno (Robert P)
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten